Leukemia, Lymphocytic, Chronic
Oncology
4
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Sanofialvocidib
BioCryst Pharmaceuticalsforodesine hydrochloride
EisaiONTAK
PfizerSGN-40
Clinical Trials (4)
Total enrollment: 226 patients across 4 trials
Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)
Start: Mar 2007Est. completion: Dec 2011165 patients
Phase 2Completed
Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)
Start: Jun 2005Est. completion: Jan 20098 patients
Phase 2Completed
Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
Start: Mar 2003Est. completion: May 200641 patients
Phase 2Completed
A Safety Study in Patients With Chronic Lymphocytic Leukemia
Start: Jul 2005Est. completion: Oct 200612 patients
Phase 1/2Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space